Physician profile
Jiping Wang
NPI 1568608669
$14,499.22
in general payments reported to CMS, 2019-2025
10 companies · $1,903 in 2025
The $1,903 reported for 2025 was more than what 80% of Surgical Oncology providers received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,939 · 2020: $53.15 · 2021: $159 · 2022: $264 · 2023: $1,525 · 2024: $7,656 · 2025: $1,903.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,400 · Travel and Lodging: $3,267 · Consulting Fee: $975 · Food and Beverage: $442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,400.00 |
| Travel and Lodging | $3,266.86 |
| Consulting Fee | $975.00 |
| Food and Beverage | $442.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $6,100.00 | 2024 | |
| Histosonics, INC. | $3,459.21 | 2024-2025 | |
| Intuitive Surgical, INC. | $2,284.34 | 2019-2023 | Da Vinci Sp |
| Medtronic, INC. | $1,120.12 | 2022-2023 | |
| Covidien LP | $905.91 | 2019 | |
| Sirtex Medical INC | $159.43 | 2021 | |
| Beigene USA, INC. | $125.00 | 2023 | Brukinsa |
| Astrazeneca Pharmaceuticals LP | $124.99 | 2023 | Imfinzi |
| Rigel Pharmaceuticals, INC. | $118.52 | 2022 | |
| Foundation Medicine, INC. | $101.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jiping Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.